Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain.
INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Int J Mol Sci. 2018 Feb 6;19(2):473. doi: 10.3390/ijms19020473.
The beneficial effects of estrogen on the cardiovascular system have been reported extensively. In fact, the incidence of cardiovascular diseases in women is lower than in age-matched men during their fertile stage of life, a benefit that disappears after menopause. These sex-related differences point to sexual hormones, mainly estrogen, as possible cardiovascular protective factors. The regulation of vascular function by estrogen is mainly related to the maintenance of normal endothelial function and is mediated by both direct and indirect gene transcription through the activity of specific estrogen receptors. Some of these mechanisms are known, but many remain to be elucidated. In recent years, microRNAs have been established as non-coding RNAs that regulate the expression of a high percentage of protein-coding genes in mammals and are related to the correct function of human physiology. Moreover, within the cardiovascular system, miRNAs have been related to physiological and pathological conditions. In this review, we address what is known about the role of estrogen-regulated miRNAs and their emerging involvement in vascular biology.
雌激素对心血管系统的有益影响已被广泛报道。事实上,在生育期,女性患心血管疾病的发病率低于同龄男性,这种益处在绝经后消失。这些与性别相关的差异表明,性激素,主要是雌激素,可能是心血管的保护因素。雌激素对血管功能的调节主要与维持正常的内皮功能有关,通过特定雌激素受体的活性,通过直接和间接的基因转录来介导。其中一些机制已经被了解,但仍有许多需要阐明。近年来,microRNAs 已被确定为非编码 RNA,可调节哺乳动物中很大一部分蛋白质编码基因的表达,并与人类生理学的正确功能有关。此外,在心血管系统中,miRNAs 与生理和病理条件有关。在这篇综述中,我们探讨了雌激素调节的 microRNAs 的作用及其在血管生物学中的新的参与情况。